Jpmorgan Chase & Co »

Agios Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Agios Pharmaceuticals shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Agios Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Agios Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Agios Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $739k 18k 40.14
2021-03-31 $1.6M 31k 51.63
2020-12-31 $2.7M 62k 43.33
2020-09-30 $1.3M 36k 34.40
2020-06-30 $2.4M 45k 53.49
2020-03-31 $2.7M 75k 35.48
2019-12-31 $1.2M 25k 47.76
2019-09-30 $810k 25k 32.40
2018-09-30 $2.3M 30k 77.13

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Meta Platforms Common (META)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Broadcom Common (AVGO)
Alphabet Common (GOOG)
Tesla Common (TSLA)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Vanguard S&p 500 Etf Fund (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Oracle Corp Common (ORCL)
Abbvie Common (ABBV)

View all positions for Jpmorgan Chase & Co

Top funds holding Agios Pharmaceuticals

Group One Trading
Jpmorgan Chase & Co
Simplex Trading

View all funds holding Agios Pharmaceuticals